CAPTIXBIO Trademark

Trademark Overview


On Tuesday, November 3, 2020, a trademark application was filed for CAPTIXBIO with the United States Patent and Trademark Office. The USPTO has given the CAPTIXBIO trademark a serial number of 79303443. The federal status of this trademark filing is REGISTERED as of Tuesday, February 8, 2022. This trademark is owned by Captix Biomedical Pty Ltd. The CAPTIXBIO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Bone implants comprising living tissue; biological bone implant material comprising living tissue; surgical implants comprised of living tissues; cell therapies, namely, living cells for medical use, stem cells for medical use, endocrine progenitor cells for medical use; pharmaceutical preparations for restoration of endocrine function and metabolic control; pharmaceutical products for restoration of endocrine function and metabolic control; cells for medical use; cells for medical purposes; stem cells for medical purposes; endocrine progenitor cells for medical use; therapeutic medical drugs for restoration of endocrine function and metabolic control; preparations for medical purposes, namely, bone implants incorporating living cells for medical purposes

Bone implants comprising artificial materials; immuno-protective devices, namely, implants made of artificial materials; implantable medical devices, namely, medical, surgical and orthopaedic implants made of artificial materials; implantable medical devices with an immune-protective function, namely, implants consisting primarily of artificial materials and also including biological materials; implantable devices for the delivery of automatic medication, namely, implants consisting primarily of artificial materials; implantable devices for medical use in measuring the composition of body fluids; medical implants made of artificial materials; orthopaedic implants of artificial materials; artificial implants; medical apparatus and instruments for use in orthopaedic medical procedures; cell culture apparatus for medical use, namely, implantable cell culture chambers; drug delivery apparatus, namely, devices carrying cells for the delivery of drugs, implantable devices carrying cells for ...
captixbio

General Information


Serial Number79303443
Word MarkCAPTIXBIO
Filing DateTuesday, November 3, 2020
Status700 - REGISTERED
Status DateTuesday, February 8, 2022
Registration Number6635082
Registration DateTuesday, February 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements


Goods and ServicesBone implants comprising living tissue; biological bone implant material comprising living tissue; surgical implants comprised of living tissues; cell therapies, namely, living cells for medical use, stem cells for medical use, endocrine progenitor cells for medical use; pharmaceutical preparations for restoration of endocrine function and metabolic control; pharmaceutical products for restoration of endocrine function and metabolic control; cells for medical use; cells for medical purposes; stem cells for medical purposes; endocrine progenitor cells for medical use; therapeutic medical drugs for restoration of endocrine function and metabolic control; preparations for medical purposes, namely, bone implants incorporating living cells for medical purposes
Translation of Words in MarkThe wording CAPTIXBIO has no meaning in a foreign language.
Goods and ServicesBone implants comprising artificial materials; immuno-protective devices, namely, implants made of artificial materials; implantable medical devices, namely, medical, surgical and orthopaedic implants made of artificial materials; implantable medical devices with an immune-protective function, namely, implants consisting primarily of artificial materials and also including biological materials; implantable devices for the delivery of automatic medication, namely, implants consisting primarily of artificial materials; implantable devices for medical use in measuring the composition of body fluids; medical implants made of artificial materials; orthopaedic implants of artificial materials; artificial implants; medical apparatus and instruments for use in orthopaedic medical procedures; cell culture apparatus for medical use, namely, implantable cell culture chambers; drug delivery apparatus, namely, devices carrying cells for the delivery of drugs, implantable devices carrying cells for the delivery of drugs, cell cargo carriers for the delivery of drugs

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, February 8, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCaptix Biomedical Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameCaptix Biomedical Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameCaptix Biomedical Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Tuesday, August 9, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 15, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 15, 2022FINAL DISPOSITION PROCESSED
Sunday, May 8, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 8, 2022REGISTERED-PRINCIPAL REGISTER
Monday, December 6, 2021NOTIFICATION PROCESSED BY IB
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 17, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 11, 2021REFUSAL PROCESSED BY IB
Monday, April 19, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 19, 2021REFUSAL PROCESSED BY MPU
Wednesday, April 14, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 13, 2021NON-FINAL ACTION WRITTEN
Thursday, April 8, 2021ASSIGNED TO EXAMINER
Friday, February 12, 2021APPLICATION FILING RECEIPT MAILED
Monday, February 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB